Skip to content

Public FDA record

Z-3231-2026: VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811

Recall record Z-3231-2026 for Biomerieux Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3231-2026
Company in FDA record
Biomerieux Inc
FDA classification date
Sep 18, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False resistant results may lead to the use of less effective antibiotic treatments or the association of multiple antibiotics having negative side effects, which could potentially impact patient s health.

Source facts

Action
An URGENT FIELD SAFETY NOTICE notification letter was sent to customers beginning 7/24/26. Required actions Dispose of any remaining inventory VITEK 2 AST-N461 TEST KIT (Ref 424811, Lot 1333393504) that were manufactured with Poucher 8 with timestamps from 10:06:00 to 11:11:59, as identified by product labeling. Inspect each pouch in inventory and dispose of cards with "P8" and timestamps between 10:06:00 to 11:11:59 on the label. Alternatively, dispose of all cards from Lot 1333393504 remaining in inventory. In accordance with your facility s policies, you may consider performing a retrospective review of clinically significant resistant results. Among tests previously performed, identify any possible false resistant results that may have occurred, analyze the related risks, and determine appropriate actions, if applicable. Please ensure that this information is communicated to all relevant personnel within your laboratory, retain a copy in your records, and forward this information to all parties that may use this product, including those to whom you may have transferred the product. Please complete the Acknowledgement Form in Attachment A and return it to your local bioMrieux representative to confirm receipt of this notice. It is important that you return the acknowledgement form to bioMrieux even if you determine that this product correction notice does not impact your facility. As a reminder, please visit the Resource Center to confirm if a reference package insert is associated with a Field Corrective Action or Field Safety Corrective Action. https://resourcecenter.biomerieux.com/ If you require additional assistance or have any questions, please contact your local bioMrieux Customer Service representative.
Initiated
2026-07-24
Root cause
Packaging process control
Distribution
International distribution to the countries of Austria, Germany, Luxembourg.
Recall number
Z-3231-2026
Recall status
Open, Classified
CDRH record ID
222401
FDA classified
2026-09-18
Recall event number
99749

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗